Hta

HTA Antihipertensivo de elección según el perfil del paciente Sara Conde-Valvís Fraga R3 MFyC Julio 2011

Introducción ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Diagnóstico >110 >180 HTA GRAVE/3 >120 >180 >210 CRISIS HTA Eu SocEspHTA >80 >120 PA NORMAL >90 >140 HTA LIGERA/1 >100 >160 HTA MOD/2 >85 >130 PA N-ALTA <80 <120 PA OPTIMA

Estratificación RCV ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Bases tratamiento ,[object Object],[object Object],[object Object],[object Object]

Hechos ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Recomendaciones ,[object Object],[object Object],[object Object],[object Object]

Objetivo tratamiento antiHTA <130/80 ,[object Object],<140/90 ,[object Object],<130/80 ,[object Object],<135/85 ,[object Object],<125/75 ,[object Object],<120/80 ,[object Object]

Medidas no farmacológicas ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Medidas farmacológicas ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Normas eleccíón antiHTA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Indicaciones ,[object Object],[object Object],[object Object],[object Object],[object Object],ARAII CA IECA D BB X X X X X X X X X

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],X X X X No dihid X X X X X X ARAII CA IECA D BB X X X ASA X X X X X X X

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],X X X ARAII CA IECA D BB X X X X X X X X

Contraindicaciones ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Estrategia inicial del tratamiento antiHTA en función RCV global

Incumplimiento terapéutico ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Estrategias ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Bibliografía ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Hta

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Andere mochten auch

Andere mochten auch (8)

Ähnlich wie Hta

Ähnlich wie Hta (20)

Mehr von Hospital Guadix

Mehr von Hospital Guadix (20)

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

Hta

Hinweis der Redaktion